Lataa...
Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia
AIM: This post hoc analysis of a double‐blind (DB), randomized, placebo‐controlled, relapse‐prevention study evaluated the effects of paliperidone palmitate once‐every‐3‐months (PP3M) in a subpopulation of adults with early illness schizophrenia (duration ≤5 years) from a clinical trial. METHODS: Pa...
Tallennettuna:
| Julkaisussa: | Early Interv Psychiatry |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley Publishing Asia Pty Ltd
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6585630/ https://ncbi.nlm.nih.gov/pubmed/29968279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/eip.12685 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|